Australia's largest stock trading and investment forum Australia's #1 stock forum

VHL vitasora health limited

5.41%

3.9¢

thanks for reinforcing your lack of understanding.

First 2255 Last

Share
Profile

Follow
lucasq

677 Posts.

322

11/11/24

21:33

Post #: 76554304
Share

Originally posted by AlCp: ↑

That's their only core product, why do you think they are pumping it recently......

Respiratory diseases diagnostics house Respiri (ASX:RSH) says it will also benefit from the American Medical Association’s (AMA’s) proposed changes to reimbursement criteria for remote patient monitoring (RPM) programs.

Respiri’s lead product is Wheezo, an app-based device to detect conditions such as asthma and chronic obstructive pulmonary disorder.

As could be expected, Wheezo is part and parcel of the remote patient management revolution.

Buoyed by the expected changes, the US-focused company today released a prezzo, outlining a total addressable market of 50,000 patients within its current client base and a “sales pipeline” of 250,000 patients.

Respiri currently has 29 clients (service providers) across 2435 patient programs.

In a nutshell, reimbursement will be made available for a lower threshold of two days of patient data collected by Wheezo over a 30-day rolling period, compared with 16 days at present.

Expand

thanks for reinforcing your lack of understanding.

RSH Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 2255 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change 0.002(5.41%)		Mkt cap ! $61.50M

Open	High	Low	Value	Volume
3.7¢	3.9¢	3.6¢	$4.769K	128.0K

Buyers (Bids)

No.	Vol.	Price($)
1	76366	3.6¢

Sellers (Offers)

Price($)	Vol.	No.
3.9¢	565213	4

View Market Depth

No.	Vol.	Price($)
1	76366	0.036
1	2816	0.035
1	300000	0.034
1	298765	0.033
2	502329	0.032

Price($)	Vol.	No.
0.039	565213	4
0.040	2315244	2
0.041	691176	2
0.042	378137	1
0.043	349998	1

Last trade - 15.59pm 27/06/2025 (20 minute delay)

VHL (ASX) Chart

thanks for reinforcing your lack of understanding.

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

thanks for reinforcing your lack of understanding.

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News